{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T09:33:57Z","timestamp":1703151237088},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T00:00:00Z","timestamp":1643328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T00:00:00Z","timestamp":1643328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s00393-021-01146-5","type":"journal-article","created":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T09:02:41Z","timestamp":1643360561000},"page":"205-211","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pr\u00e4operative An\u00e4mie beim Rheumatiker"],"prefix":"10.1007","volume":"81","author":[{"given":"Lena","family":"B\u00f6hm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Schmalzing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Meybohm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,28]]},"reference":[{"key":"1146_CR1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.atherosclerosis.2016.11.009","volume":"256","author":"R Gualtierotti","year":"2017","unstructured":"Gualtierotti\u00a0R (2017) Understanding cardiovascular risk in rheumatoid arthritis: still a\u00a0long way to go. Atherosclerosis 256:123\u2013124. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.11.009","journal-title":"Atherosclerosis"},{"key":"1146_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/ar2669","volume":"11","author":"SE Gabriel","year":"2009","unstructured":"Gabriel\u00a0SE, Michaud\u00a0K (2009) Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther 11:229. https:\/\/doi.org\/10.1186\/ar2669","journal-title":"Arthritis Res Ther"},{"key":"1146_CR3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1136\/ard.49.2.93","volume":"49","author":"G Vreugdenhil","year":"1990","unstructured":"Vreugdenhil\u00a0G, Wognum\u00a0AW, van Eijk\u00a0HG et\u00a0al (1990) Anaemia in rheumatoid arthritis: the role of iron, vitamin B12, and folic acid deficiency, and erythropoietin responsiveness. Ann Rheum Dis 49:93\u201398. https:\/\/doi.org\/10.1136\/ard.49.2.93","journal-title":"Ann Rheum Dis"},{"key":"1146_CR4","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1080\/17453670610012782","volume":"77","author":"R Slappendel","year":"2006","unstructured":"Slappendel\u00a0R, Weber\u00a0EW, Hemon\u00a0YJ et al (2006) Patients with and without rheumatoid arthritis benefit equally from preoperative epoetin-alpha treatment. Acta Orthop 77:677\u2013683. https:\/\/doi.org\/10.1080\/17453670610012782","journal-title":"Acta Orthop"},{"key":"1146_CR5","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1046\/j.1537-2995.2003.00348.x","volume":"43","author":"N Rosencher","year":"2003","unstructured":"Rosencher\u00a0N, Kerkkamp\u00a0HE, Macheras\u00a0G et\u00a0al (2003) Orthopedic surgery transfusion hemoglobin European overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in europe. Transfusion 43:459\u2013469. https:\/\/doi.org\/10.1046\/j.1537-2995.2003.00348.x","journal-title":"Transfusion"},{"key":"1146_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1001\/archsurg.2011.790","volume":"147","author":"VA Ferraris","year":"2012","unstructured":"Ferraris\u00a0VA, Davenport\u00a0DL, Saha\u00a0SP et\u00a0al (2012) Surgical outcomes and transfusion of minimal amounts of blood in the operating room. Arch Surg 147:49\u201355. https:\/\/doi.org\/10.1001\/archsurg.2011.790","journal-title":"Arch Surg"},{"key":"1146_CR7","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1093\/bja\/aeu098","volume":"113","author":"DM Baron","year":"2014","unstructured":"Baron\u00a0DM, Hochrieser\u00a0H, Posch\u00a0M et al (2014) Preoperative anaemia is associated with poor clinical outcome in non-cardiac surgery patients. Br J Anaesth 113:416\u2013423. https:\/\/doi.org\/10.1093\/bja\/aeu098","journal-title":"Br J Anaesth"},{"key":"1146_CR8","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/S0140-6736(11)61381-0","volume":"378","author":"KM Musallam","year":"2011","unstructured":"Musallam\u00a0KM, Tamim\u00a0HM, Richards\u00a0T et al (2011) Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a\u00a0retrospective cohort study. Lancet 378:1396\u20131407. https:\/\/doi.org\/10.1016\/S0140-6736(11)61381-0","journal-title":"Lancet"},{"key":"1146_CR9","doi-asserted-by":"publisher","first-page":"189","DOI":"10.4103\/0256-4947.51774","volume":"29","author":"A Al-Ghamdi","year":"2009","unstructured":"Al-Ghamdi\u00a0A, Attar\u00a0SM (2009) Extra-articular manifestations of rheumatoid arthritis: a\u00a0hospital-based study. Ann Saudi Med 29:189\u2013193. https:\/\/doi.org\/10.4103\/0256-4947.51774","journal-title":"Ann Saudi Med"},{"key":"1146_CR10","first-page":"560","volume":"27","author":"DE Furst","year":"2009","unstructured":"Furst\u00a0DE, Chang\u00a0H, Greenberg\u00a0JD et\u00a0al (2009) Prevalence of low hemoglobin levels and associations with other disease parameters in rheumatoid arthritis patients: evidence from the CORRONA registry. Clin Exp Rheumatol 27:560\u2013566","journal-title":"Clin Exp Rheumatol"},{"issue":"7A","key":"1146_CR11","doi-asserted-by":"publisher","first-page":"50S","DOI":"10.1016\/j.amjmed.2003.12.012","volume":"116","author":"A Wilson","year":"2004","unstructured":"Wilson\u00a0A, Yu\u00a0HT, Goodnough\u00a0LT et\u00a0al (2004) Prevalence and outcomes of anemia in rheumatoid arthritis: a\u00a0systematic review of the literature. Am J Med 116(7A):50S\u201357S. https:\/\/doi.org\/10.1016\/j.amjmed.2003.12.012","journal-title":"Am J Med"},{"key":"1146_CR12","unstructured":"World Health Organization (WHO) Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information System 2011. p\u00a01\u20136. WHO Reference Number: WHO\/NMH\/NHD\/MNM\/11.1"},{"key":"1146_CR13","doi-asserted-by":"publisher","first-page":"42","DOI":"10.5606\/tjr.2014.3538","volume":"29","author":"MT Vatutin","year":"2014","unstructured":"Vatutin\u00a0MT, Smyrnova\u00a0G, Shevelyok\u00a0A et\u00a0al (2014) Differential diagnosis of anemia in patients with rheumatoid arthritis. Arch Rheumatol 29:42\u201346. https:\/\/doi.org\/10.5606\/tjr.2014.3538","journal-title":"Arch Rheumatol"},{"key":"1146_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000332.pub3:","author":"AJ Marti-Carvajal","year":"2013","unstructured":"Marti-Carvajal\u00a0AJ, Agreda-Perez\u00a0LH, Sola\u00a0I et al (2013) Erythropoiesis-stimulating agents for anemia in rheumatoid arthritis. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD000332.pub3:","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"1146_CR15","first-page":"S11","volume":"65","author":"BN Cronstein","year":"2007","unstructured":"Cronstein\u00a0BN (2007) Interleukin-6\u2014a key mediator of systemic and local symptoms in rheumatoid arthritis. Bull NYU Hosp Jt Dis 65(1):S11\u201315","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"1146_CR16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/rheumatology\/kep329","volume":"49","author":"JM Dayer","year":"2010","unstructured":"Dayer\u00a0JM, Choy\u00a0E (2010) Therapeutic targets in rheumatoid arthritis: the interleukin\u20116 receptor. Rheumatology (Oxford) 49:15\u201324. https:\/\/doi.org\/10.1093\/rheumatology\/kep329","journal-title":"Rheumatology (Oxford)"},{"key":"1146_CR17","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.autrev.2009.01.012","volume":"8","author":"JE Fonseca","year":"2009","unstructured":"Fonseca\u00a0JE, Santos\u00a0MJ, Canhao\u00a0H et al (2009) Interleukin\u20116 as a\u00a0key player in systemic inflammation and joint destruction. Autoimmun Rev 8:538\u2013542. https:\/\/doi.org\/10.1016\/j.autrev.2009.01.012","journal-title":"Autoimmun Rev"},{"key":"1146_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev.immunol.23.021704.115806","volume":"23","author":"T Kishimoto","year":"2005","unstructured":"Kishimoto\u00a0T (2005) Interleukin-6: from basic science to medicine\u201440\u00a0years in immunology. Annu Rev Immunol 23:1\u201321. https:\/\/doi.org\/10.1146\/annurev.immunol.23.021704.115806","journal-title":"Annu Rev Immunol"},{"key":"1146_CR19","first-page":"380","volume":"35","author":"C Nikolaisen","year":"2008","unstructured":"Nikolaisen\u00a0C, Figenschau\u00a0Y, Nossent\u00a0JC (2008) Anemia in early rheumatoid arthritis is associated with interleukin 6\u2011mediated bone marrow suppression, but has no effect on disease course or mortality. J\u00a0Rheumatol 35:380\u2013386","journal-title":"J Rheumatol"},{"key":"1146_CR20","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jbspin.2010.05.017","volume":"78","author":"C Masson","year":"2011","unstructured":"Masson\u00a0C (2011) Rheumatoid anemia. Joint Bone Spine 78:131\u2013137. https:\/\/doi.org\/10.1016\/j.jbspin.2010.05.017","journal-title":"Joint Bone Spine"},{"key":"1146_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5114\/reum.2019.83232","volume":"57","author":"A Filipowicz-Sosnowska","year":"2019","unstructured":"Filipowicz-Sosnowska\u00a0A (2019) Comorbidities and multimorbidity in rheumatic diseases. Reumatologia 57:1\u20132. https:\/\/doi.org\/10.5114\/reum.2019.83232","journal-title":"Reumatologia"},{"key":"1146_CR22","first-page":"102","volume":"20","author":"B Polster","year":"2013","unstructured":"Polster\u00a0B, Mustak\u00a0M (2013) Patients with rheumatoid diseases around surgery and at intensive care units: what needs to be considered? J\u00a0Miner Stoffwechs Muskuloskelet Erkrank 20:102\u2013107","journal-title":"J. Miner. Stoffwechs. Muskuloskelet. Erkrank."},{"key":"1146_CR23","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1093\/rheumatology\/kep252","volume":"48","author":"C Meune","year":"2009","unstructured":"Meune\u00a0C, Touze\u00a0E, Trinquart\u00a0L et al (2009) Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50\u00a0years: a\u00a0systematic review and meta-analysis of cohort studies. Rheumatology (Oxford) 48:1309\u20131313. https:\/\/doi.org\/10.1093\/rheumatology\/kep252","journal-title":"Rheumatology (Oxford)"},{"key":"1146_CR24","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s00101-013-2199-1","volume":"62","author":"H Gombotz","year":"2013","unstructured":"Gombotz\u00a0H, Hofmann\u00a0A (2013) Patient blood management : three pillar strategy to improve outcome through avoidance of allogeneic blood products. Anaesthesist 62:519\u2013527. https:\/\/doi.org\/10.1007\/s00101-013-2199-1","journal-title":"Anaesthesist"},{"key":"1146_CR25","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1097\/ALN.0b013e31819878d3","volume":"110","author":"WS Beattie","year":"2009","unstructured":"Beattie\u00a0WS, Karkouti\u00a0K, Wijeysundera\u00a0DN et al (2009) Risk associated with preoperative anemia in noncardiac surgery: a\u00a0single-center cohort study. Anesthesiology 110:574\u2013581. https:\/\/doi.org\/10.1097\/ALN.0b013e31819878d3","journal-title":"Anesthesiology"},{"key":"1146_CR26","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1002\/bjs.9861","volume":"102","author":"AJ Fowler","year":"2015","unstructured":"Fowler\u00a0AJ, Ahmad\u00a0T, Phull\u00a0MK et al (2015) Meta-analysis of the association between preoperative anaemia and mortality after surgery. Br J Surg 102:1314\u20131324. https:\/\/doi.org\/10.1002\/bjs.9861","journal-title":"Br J Surg"},{"key":"1146_CR27","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.jtcvs.2013.06.033","volume":"146","author":"G Loor","year":"2013","unstructured":"Loor\u00a0G, Rajeswaran\u00a0J, Li\u00a0L et\u00a0al (2013) The least of 3 evils: exposure to red blood cell transfusion, anemia, or both? J\u00a0Thorac Cardiovasc Surg 146:1480\u20131487.e6. https:\/\/doi.org\/10.1016\/j.jtcvs.2013.06.033","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1146_CR28","doi-asserted-by":"publisher","first-page":"931\u20137","DOI":"10.1016\/j.jamcollsurg.2008.11.019","volume":"208","author":"AC Bernard","year":"2009","unstructured":"Bernard\u00a0AC, Davenport\u00a0DL, Chang\u00a0PK et al (2009) Intraoperative transfusion of 1U to 2U packed red blood cells is associated with increased 30-day mortality, surgical-site infection, pneumonia, and sepsis in general surgery patients. J\u00a0Am Coll Surg 208:931\u20137\u2013937.e1\u20132. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2008.11.019 (discussion 938\u2013939)","journal-title":"J Am Coll Surg"},{"key":"1146_CR29","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1016\/S0140-6736(15)01313-6","volume":"388","author":"M Delaney","year":"2016","unstructured":"Delaney\u00a0M, Wendel\u00a0S, Bercovitz\u00a0RS et\u00a0al (2016) Transfusion reactions: prevention, diagnosis, and treatment. Lancet 388:2825\u20132836. https:\/\/doi.org\/10.1016\/S0140-6736(15)01313-6","journal-title":"Lancet"},{"key":"1146_CR30","doi-asserted-by":"publisher","first-page":"h3037","DOI":"10.1136\/bmj.h3037","volume":"350","author":"EL Whitlock","year":"2015","unstructured":"Whitlock\u00a0EL, Kim\u00a0H, Auerbach\u00a0AD (2015) Harms associated with single unit perioperative transfusion: retrospective population based analysis. BMJ 350:h3037. https:\/\/doi.org\/10.1136\/bmj.h3037","journal-title":"BMJ"},{"key":"1146_CR31","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/00000542-200007000-00035","volume":"93","author":"DR Spahn","year":"2000","unstructured":"Spahn\u00a0DR, Casutt\u00a0M (2000) Eliminating blood transfusions: new aspects and perspectives. Anesthesiology 93:242\u2013255. https:\/\/doi.org\/10.1097\/00000542-200007000-00035","journal-title":"Anesthesiology"},{"key":"1146_CR32","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1046\/j.1537-2995.1996.36296181932.x","volume":"36","author":"EC Vamvakas","year":"1996","unstructured":"Vamvakas\u00a0EC (1996) Transfusion-associated cancer recurrence and postoperative infection: meta-analysis of randomized, controlled clinical trials. Transfusion 36:175\u2013186. https:\/\/doi.org\/10.1046\/j.1537-2995.1996.36296181932.x","journal-title":"Transfusion"},{"key":"1146_CR33","doi-asserted-by":"publisher","first-page":"193","DOI":"10.18773\/austprescr.2016.069","volume":"39","author":"J Baird-Gunning","year":"2016","unstructured":"Baird-Gunning\u00a0J, Bromley\u00a0J (2016) Correcting iron deficiency. Aust Prescr 39:193\u2013199. https:\/\/doi.org\/10.18773\/austprescr.2016.069","journal-title":"Aust Prescr"},{"key":"1146_CR34","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/anae.15396","volume":"76","author":"CR Evans","year":"2021","unstructured":"Evans\u00a0CR, Jones\u00a0R, Phillips\u00a0G et al (2021) Observational study of pre-operative intravenous iron given to anaemic patients before elective cardiac surgery. Anaesthesia 76:639\u2013646. https:\/\/doi.org\/10.1111\/anae.15396","journal-title":"Anaesthesia"},{"key":"1146_CR35","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1016\/S0140-6736(18)32555-8","volume":"393","author":"DR Spahn","year":"2019","unstructured":"Spahn\u00a0DR, Schoenrath\u00a0F, Spahn\u00a0GH et al (2019) Effect of ultra-short-term treatment of patients with iron deficiency or anaemia undergoing cardiac surgery: a\u00a0prospective randomised trial. Lancet 393:2201\u20132212. https:\/\/doi.org\/10.1016\/S0140-6736(18)32555-8","journal-title":"Lancet"},{"key":"1146_CR36","doi-asserted-by":"publisher","first-page":"18403","DOI":"10.1038\/s41598-020-75535-2","volume":"10","author":"A Ionescu","year":"2020","unstructured":"Ionescu\u00a0A, Sharma\u00a0A, Kundnani\u00a0NR et al (2020) Intravenous iron infusion as an alternative to minimize blood transfusion in peri-operative patients. Sci Rep 10:18403. https:\/\/doi.org\/10.1038\/s41598-020-75535-2","journal-title":"Sci Rep"},{"key":"1146_CR37","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000003643","author":"C Triphaus","year":"2019","unstructured":"Triphaus\u00a0C, Judd\u00a0L, Glaser\u00a0P et\u00a0al (2019) Effectiveness of preoperative iron supplementation in major surgical patients with iron deficiency: a prospective observational study. Ann Surg. https:\/\/doi.org\/10.1097\/SLA.0000000000003643","journal-title":"Ann Surg"},{"key":"1146_CR38","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1136\/ard.44.3.183","volume":"44","author":"DR Blake","year":"1985","unstructured":"Blake\u00a0DR, Lunec\u00a0J, Ahern\u00a0M et\u00a0al (1985) Effect of intravenous iron dextran on rheumatoid synovitis. Ann Rheum Dis 44:183\u2013188. https:\/\/doi.org\/10.1136\/ard.44.3.183","journal-title":"Ann Rheum Dis"},{"key":"1146_CR39","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/art.1780120413","volume":"12","author":"PS Reddy","year":"1969","unstructured":"Reddy\u00a0PS, Lewis\u00a0M (1969) The adverse effect of intravenous iron-dextran in rheumatoid arthritis. Arthritis Rheum 12:454\u2013457. https:\/\/doi.org\/10.1002\/art.1780120413","journal-title":"Arthritis Rheum"},{"key":"1146_CR40","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1136\/bmj.2.5705.323","volume":"2","author":"KN Lloyd","year":"1970","unstructured":"Lloyd\u00a0KN, Williams\u00a0P (1970) Reactions to total dose infusion of iron dextran in rheumatoid arthritis. Br Med\u00a0J 2:323\u2013325. https:\/\/doi.org\/10.1136\/bmj.2.5705.323","journal-title":"Br Med J"},{"key":"1146_CR41","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/BF02247854","volume":"16","author":"MA Cimmino","year":"1997","unstructured":"Cimmino\u00a0MA, Parisi\u00a0M, Querci\u00a0G et\u00a0al (1997) Intravenous iron is effective in treating the anaemia of rheumatoid arthritis and is not associated with flares of synovitis. Clin Rheumatol 16:215\u2013216. https:\/\/doi.org\/10.1007\/BF02247854","journal-title":"Clin Rheumatol"},{"key":"1146_CR42","first-page":"i158","volume":"49","author":"R Tsang","year":"2010","unstructured":"Tsang\u00a0R, Coulson\u00a0E, Saravanan\u00a0V et\u00a0al (2010) Efficacy and safety of intravenous iron in rheumatoid arthritis. Rheumatology (Oxford) 49:i158\u2013i159","journal-title":"Rheumatology (Oxford)"},{"key":"1146_CR43","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s10067-011-1885-0","volume":"31","author":"WS Chen","year":"2012","unstructured":"Chen\u00a0WS, Liu\u00a0CY, Lee\u00a0HT et\u00a0al (2012) Effects of intravenous iron saccharate on improving severe anemia in rheumatoid arthritis patients. Clin Rheumatol 31:469\u2013477. https:\/\/doi.org\/10.1007\/s10067-011-1885-0","journal-title":"Clin Rheumatol"},{"key":"1146_CR44","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.semarthrit.2008.08.002","volume":"39","author":"MK Doyle","year":"2009","unstructured":"Doyle\u00a0MK, Rahman\u00a0MU, Han\u00a0C et al (2009) Treatment with infliximab plus methotrexate improves anemia in patients with rheumatoid arthritis independent of improvement in other clinical outcome measures\u2011a pooled analysis from three large, multicenter, double-blind, randomized clinical trials. Semin Arthritis Rheum 39:123\u2013131. https:\/\/doi.org\/10.1016\/j.semarthrit.2008.08.002","journal-title":"Semin Arthritis Rheum"},{"key":"1146_CR45","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1002\/art.23940","volume":"58","author":"MC Genovese","year":"2008","unstructured":"Genovese\u00a0MC, McKay\u00a0JD, Nasonov\u00a0EL et al (2008) Interleukin\u20116 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study. Arthritis Rheum 58:2968\u20132980. https:\/\/doi.org\/10.1002\/art.23940","journal-title":"Arthritis Rheum"},{"key":"1146_CR46","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1002\/anr.1780320519","volume":"32","author":"RT Means Jr.","year":"1989","unstructured":"Means\u00a0RT Jr., Olsen\u00a0NJ, Krantz\u00a0SB et\u00a0al (1989) Treatment of the anemia of rheumatoid arthritis with recombinant human erythropoietin: clinical and in vitro studies. Arthritis Rheum 32:638\u2013642. https:\/\/doi.org\/10.1002\/anr.1780320519","journal-title":"Arthritis Rheum"},{"key":"1146_CR47","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1182\/blood.V77.3.419.419","volume":"77","author":"SB Krantz","year":"1991","unstructured":"Krantz\u00a0SB (1991) Erythropoietin. Blood 77:419\u2013434","journal-title":"Blood"},{"key":"1146_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/153537020322800101","volume":"228","author":"JW Fisher","year":"2003","unstructured":"Fisher\u00a0JW (2003) Erythropoietin: physiology and pharmacology update. Exp Biol Med (Maywood) 228:1\u201314. https:\/\/doi.org\/10.1177\/153537020322800101","journal-title":"Exp Biol Med (Maywood)"},{"key":"1146_CR49","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1152\/physrev.1992.72.2.449","volume":"72","author":"W Jelkmann","year":"1992","unstructured":"Jelkmann\u00a0W (1992) Erythropoietin: structure, control of production, and function. Physiol Rev 72:449\u2013489. https:\/\/doi.org\/10.1152\/physrev.1992.72.2.449","journal-title":"Physiol Rev"},{"key":"1146_CR50","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1097\/01.asn.0000071514.36428.61","volume":"14","author":"AC Cooper","year":"2003","unstructured":"Cooper\u00a0AC, Mikhail\u00a0A, Lethbridge\u00a0MW et al (2003) Increased expression of erythropoiesis inhibiting cytokines (IFN-gamma, TNF-alpha, IL-10, and IL-13) by T cells in patients exhibiting a\u00a0poor response to erythropoietin therapy. J\u00a0Am Soc Nephrol 14:1776\u20131784. https:\/\/doi.org\/10.1097\/01.asn.0000071514.36428.61","journal-title":"J Am Soc Nephrol"},{"key":"1146_CR51","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/0002-9343(90)90294-n","volume":"89","author":"T Pincus","year":"1990","unstructured":"Pincus\u00a0T, Olsen\u00a0NJ, Russell\u00a0IJ et\u00a0al (1990) Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis. Am J Med 89:161\u2013168. https:\/\/doi.org\/10.1016\/0002-9343(90)90294-n","journal-title":"Am J Med"},{"key":"1146_CR52","first-page":"885","volume":"17","author":"N Takashina","year":"1990","unstructured":"Takashina\u00a0N, Kondo\u00a0H, Kashiwazaki\u00a0S (1990) Suppressed serum erythropoietin response to anemia and the efficacy of recombinant erythropoietin in the anemia of rheumatoid arthritis. J\u00a0Rheumatol 17:885\u2013887","journal-title":"J Rheumatol"},{"key":"1146_CR53","first-page":"1168","volume":"18","author":"C Salvarani","year":"1991","unstructured":"Salvarani\u00a0C, Lasagni\u00a0D, Casali\u00a0B et\u00a0al (1991) Recombinant human erythropoietin therapy in patients with rheumatoid arthritis with the anemia of chronic disease. J\u00a0Rheumatol 18:1168\u20131171","journal-title":"J Rheumatol"},{"key":"1146_CR54","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1136\/ard.51.6.747","volume":"51","author":"B Gudbjornsson","year":"1992","unstructured":"Gudbjornsson\u00a0B, Hallgren\u00a0R, Wide\u00a0L et\u00a0al (1992) Response of anaemia in rheumatoid arthritis to treatment with subcutaneous recombinant human erythropoietin. Ann Rheum Dis 51:747\u2013752. https:\/\/doi.org\/10.1136\/ard.51.6.747","journal-title":"Ann Rheum Dis"},{"key":"1146_CR55","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3109\/03009749309099269","volume":"22","author":"T Pettersson","year":"1993","unstructured":"Pettersson\u00a0T, Rosenlof\u00a0K, Friman\u00a0C et\u00a0al (1993) Successful treatment of the anemia of rheumatoid arthritis with subcutaneously administered recombinant human erythropoietin. Slower response in patients with more severe inflammation. Scand J Rheumatol 22:188\u2013193. https:\/\/doi.org\/10.3109\/03009749309099269","journal-title":"Scand J Rheumatol"},{"key":"1146_CR56","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2169\/internalmedicine.33.193","volume":"33","author":"Y Kato","year":"1994","unstructured":"Kato\u00a0Y, Takagi\u00a0C, Tanaka\u00a0J et\u00a0al (1994) Effect of daily subcutaneous administration of recombinant erythropoietin on chronic anemia in rheumatoid arthritis. Intern Med 33:193\u2013197. https:\/\/doi.org\/10.2169\/internalmedicine.33.193","journal-title":"Intern Med"},{"key":"1146_CR57","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1136\/bmj.309.6965.1337","volume":"309","author":"EA Murphy","year":"1994","unstructured":"Murphy\u00a0EA, Bell\u00a0AL, Wojtulewski\u00a0J et\u00a0al (1994) Study of erythropoietin in treatment of anaemia in patients with rheumatoid arthritis. BMJ 309:1337\u20131338. https:\/\/doi.org\/10.1136\/bmj.309.6965.1337","journal-title":"BMJ"},{"key":"1146_CR58","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s002960050011","volume":"17","author":"D Nordstrom","year":"1997","unstructured":"Nordstrom\u00a0D, Lindroth\u00a0Y, Marsal\u00a0L et\u00a0al (1997) Availability of iron and degree of inflammation modifies the response to recombinant human erythropoietin when treating anemia of chronic disease in patients with rheumatoid arthritis. Rheumatol Int 17:67\u201373. https:\/\/doi.org\/10.1007\/s002960050011","journal-title":"Rheumatol Int"},{"key":"1146_CR59","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/0272-6386(95)90151-5","volume":"26","author":"S Fishbane","year":"1995","unstructured":"Fishbane\u00a0S, Frei\u00a0GL, Maesaka\u00a0J (1995) Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation. Am J Kidney Dis 26:41\u201346. https:\/\/doi.org\/10.1016\/0272-6386(95)90151-5","journal-title":"Am J Kidney Dis"},{"key":"1146_CR60","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1046\/j.1523-1755.1999.055suppl.69049.x","volume":"69","author":"JP Kaltwasser","year":"1999","unstructured":"Kaltwasser\u00a0JP, Gottschalk\u00a0R (1999) Erythropoietin and iron. Kidney Int Suppl 69:S49\u201356. https:\/\/doi.org\/10.1046\/j.1523-1755.1999.055suppl.69049.x","journal-title":"Kidney Int Suppl"},{"key":"1146_CR61","first-page":"2070","volume":"10","author":"G Sunder-Plassmann","year":"1995","unstructured":"Sunder-Plassmann\u00a0G, Horl\u00a0WH (1995) Importance of iron supply for erythropoietin therapy. Nephrol Dial Transplant 10:2070\u20132076","journal-title":"Nephrol Dial Transplant"},{"key":"1146_CR62","first-page":"2430","volume":"28","author":"JP Kaltwasser","year":"2001","unstructured":"Kaltwasser\u00a0JP, Kessler\u00a0U, Gottschalk\u00a0R et\u00a0al (2001) Effect of recombinant human erythropoietin and intravenous iron on anemia and disease activity in rheumatoid arthritis. J\u00a0Rheumatol 28:2430\u20132436","journal-title":"J Rheumatol"},{"key":"1146_CR63","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1136\/ard.55.10.739","volume":"55","author":"HR Peeters","year":"1996","unstructured":"Peeters\u00a0HR, Jongen-Lavrencic\u00a0M, Vreugdenhil\u00a0G et al (1996) Effect of recombinant human erythropoietin on anaemia and disease activity in patients with rheumatoid arthritis and anaemia of chronic disease: a\u00a0randomised placebo controlled double blind 52\u00a0weeks clinical trial. Ann Rheum Dis 55:739\u2013744. https:\/\/doi.org\/10.1136\/ard.55.10.739","journal-title":"Ann Rheum Dis"},{"key":"1146_CR64","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00277-004-0950-z","volume":"84","author":"U Arndt","year":"2005","unstructured":"Arndt\u00a0U, Kaltwasser\u00a0JP, Gottschalk\u00a0R et al (2005) Correction of iron-deficient erythropoiesis in the treatment of anemia of chronic disease with recombinant human erythropoietin. Ann Hematol 84:159\u2013166. https:\/\/doi.org\/10.1007\/s00277-004-0950-z","journal-title":"Ann Hematol"},{"key":"1146_CR65","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1093\/rheumatology\/32.3.204","volume":"32","author":"R Kendall","year":"1993","unstructured":"Kendall\u00a0R, Wasti\u00a0A, Harvey\u00a0A et\u00a0al (1993) The relationship of haemoglobin to serum erythropoietin concentrations in the anaemia of rheumatoid arthritis: the effect of oral prednisolone. Br J Rheumatol 32:204\u2013208. https:\/\/doi.org\/10.1093\/rheumatology\/32.3.204","journal-title":"Br J Rheumatol"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-021-01146-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00393-021-01146-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-021-01146-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T17:08:22Z","timestamp":1648660102000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00393-021-01146-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,28]]},"references-count":65,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["1146"],"URL":"https:\/\/doi.org\/10.1007\/s00393-021-01146-5","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,28]]},"assertion":[{"value":"30 November 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"L.\u00a0B\u00f6hm und M.\u00a0Schmalzing geben an, dass kein Interessenkonflikt besteht. P.\u00a0Meybohm erhielt F\u00f6rderungen oder Reisekostenunterst\u00fctzung f\u00fcr Beratungen und Vortr\u00e4ge von Belgien Red Cross, Biotest, CSL Behring GmbH, Bundesamt f\u00fcr Bev\u00f6lkerungsschutz und Katastrophenhilfe (BKK), Fresenius, Haemonetics, Landes\u00e4rztekammer Sachsen, Landes\u00e4rztekammer Hessen, Masimo, Radiometer, Sch\u00f6chl medical Education, Thieme-Verlag, Trillium Diagnostik, Werfen GmbH, Vifor Pharma GmbH.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}